This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
Last month, the 2025 American Diabetes Association (ADA) guidelines were introduced, providing updates for diagnosing and managing diabetes and prediabetes. This ensures patients have contingency plans to maintain effective diabetes management during periods of unavailability.
Nature Reviews Cardiology, Published online: 13 January 2025; doi:10.1038/s41569-024-01115-w In this Review, Khan and Jandeleit-Dahm discuss pathological mechanisms involved in atherosclerosis development and progression in patients with diabetes mellitus and highlight novel therapeutic targets to treat atherosclerosis in these patients.
In this episode, hosts explore the latest updates to the ADA Standards of Care on therapeutic innovations and their real-world impact on diabetes management.
In the first of 2 episodes spotlighting the meeting, hosts break down news and updates from the Advanced Technologies and Treatments for Diabetes meeting.
The first quarter of 2025 saw approvals in diabetes, depression, kidney disease, and pain, among others. Read more about high-impact approvals of Q1 now.
tim.hodson Fri, 03/14/2025 - 11:42 March 11, 2025 CareDx, Inc. Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. 5 As with other organ transplants, the organs are at risk of rejection.
18, 2025 About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and obesity.[1] DALLAS, Feb. 1] This cluster of chronic health conditions is called.
tim.hodson Tue, 03/11/2025 - 11:19 Mar. 10, 2025-- Corcept Therapeutics Inc., Momentums design is similar to Corcepts CATALYST clinical trial, which demonstrated that one in four patients with difficult-to-control type 2 diabetes has hypercortisolism. Patients with a dexamethasone suppression test (DST) value greater than 1.8
DALLAS, April 1, 2025 A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted her career to identifying ways.
This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025. Vitadio : Digital therapeutics for type 2 diabetes and prediabetes, expanding globally. LumineticsCore : An AI diagnostics company with FDA-cleared systems for detecting diabetic retinopathy.
Stroke, Volume 56, Issue Suppl_1 , Page ATP31-ATP31, February 1, 2025. Diabetes increases the risk of Vascular Contributions to Cognitive Impairment&Dementia (VCID) and stroke further amplifies this effect. Diabetes also dysregulates the Endothelin (ET) system.
Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025. Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP116-ATMP116, February 1, 2025. Background and Purpose:Gut microbiota dysfunction is associated with diabetic cognitive impairment (DCI). However, the mechanisms underlying the interaction of gut microbiota dysbiosis and DCI remain poorly understood.
Stroke, Volume 56, Issue Suppl_1 , Page ATP392-ATP392, February 1, 2025. Diabetes is a widespread disease, and stroke is one of the serious complications of diabetes. Antidiabetic therapy increases the risk of recurrent hypoglycemia (RH). However, the total duration for which these perfusion deficits last is unknown.
Stroke, Volume 56, Issue Suppl_1 , Page ATP43-ATP43, February 1, 2025. Since diabetes increases VCID risk, our first goal was to develop a multi-etiology model of VCID in diabetes. ETARs, hypoxia marker HIF1, and senescence marker p21 levels were increased in the UCCAO+ME diabetic group; while ETBRs rather decreased.
Haechan Cho, MD received Best Abstract first runner-up after presenting his abstract, “Coronary Computed Tomography Angiography Versus Functional Testing In Patients With Diabetes And Suspected Coronary Artery Disease: Real-world Evidence From The Nationwide Cohort.” and the Ma Family, who provided a $5,000 case prize for the winner.
Publication date: Available online 3 February 2025 Source: The American Journal of Cardiology Author(s): Giuseppe Tavilla, Md Anamul Islam, Amber Malhotra, Daniel Lincoln Beckles
Publication date: Available online 17 March 2025 Source: The American Journal of Cardiology Author(s): Muhammad Hanif, Allison G. Hays, Jai S. Nagarajan, Shiva P. Sah, Ruth S. Weinstock, Cynthia C.
Publication date: Available online 7 March 2025 Source: The American Journal of Cardiology Author(s): Yong-Hoon Yoon, Tae oh Kim, Gyung-Min Park, Jong-Young Lee, Jae-Hyung Roh, Jae-Hwan Lee, Kyusup Lee, Pil Hyung Lee, Jaewon Choe, Young-Hak Kim, Seung-Whan Lee
Publication date: Available online 7 March 2025 Source: The American Journal of Cardiology Author(s): George G. Kidess, Mohammad Hamza, Rohit Goru, Jawad Basit, Mowaffak Alraiyes, M Chadi Alraies
On-demand access is available now and will remain open until December 2025. Diabetes Management: Gain insights into precision medicine, advanced insulin therapies, and continuous glucose monitoring (CGM) for cardiovascular risk assessment. When Will It Be Available?
Publication date: Available online 11 January 2025 Source: The American Journal of Cardiology Author(s): Annunziata Nusca, Maria Pia Di Bitonto, Agostino Span, Bernardini Federico, Fabio Mangiacapra, Elisabetta Ricottini, Rosetta Melfi, Sara Giannone, Gian Paolo Ussia, Francesco Grigioni
Stroke, Volume 56, Issue Suppl_1 , Page ATP9-ATP9, February 1, 2025. Hemorrhagic transformation (HT), a complication of IVT, is more frequent in acute hyperglycemia and diabetes (DM) and is associated with poor clinical outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page ATP350-ATP350, February 1, 2025. Type 2 diabetes mellitus (T2DM) induces chronic inflammation, which can worsen the secondary injury following ischemic stroke.
Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. The association remained significant after adjustment for age, race, gender, hypertension, diabetes, smoking status, education level and regular dental care use (Adjusted OR 0.61 However, the impact of preventative oral behavior such as dental flossing is unknown.
Stroke, Volume 56, Issue Suppl_1 , Page A51-A51, February 1, 2025. Background:Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown a reduction in major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM).
Stroke, Volume 56, Issue Suppl_1 , Page ATP146-ATP146, February 1, 2025. AIS hospitalizations were identified based on a primary diagnosis of ICD 10 CM code I63, and risk factors (RFs) (hypertension, diabetes, hyperlipidemia, and tobacco use) were identified using secondary diagnoses codes. vs. 33.8%, PR: 1.6), 35-54 years (86.7%
Stroke, Volume 56, Issue Suppl_1 , Page ATP217-ATP217, February 1, 2025. Introduction:Craniocervical arterial dissection (CCAD) accounts for only a small proportion of ischemic stroke, but it represents 20 to 25% of cases among younger adults. The prognosis of CCAD is generally favorable. p>0.05.
Stroke, Volume 56, Issue Suppl_1 , Page ATP48-ATP48, February 1, 2025. Over half of the subjects with strokes were females (55 (63.2%)), diabetic (44 (50.6%)), hypertensive (58 (66.7%)), and had metabolic syndrome (44 (50.6%)). Mixed linear models adjusted for age and education showed that diabetes (Beta: -1.4,
Florez, MD, PhD , explored the future of precision medicine in diabetes. Looking Ahead: The Future of Cardiorenal Metabolic Medicine For those unable to attend, on-demand access to the 19th Annual CMHC content will be available from December 2024 to December 2025. Learn more now!
Stroke, Volume 56, Issue Suppl_1 , Page ATP268-ATP268, February 1, 2025. Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heart attack.
Stroke, Volume 56, Issue 3 , Page 640-648, March 1, 2025. BACKGROUND:Stroke incidence is decreasing in older ages but increasing in young adults. The causal effect of body mass index on stroke was significantly stronger for EOS than for LOS (odds ratio, 1.26 versus 1.03;P=0.008).
They had lower risks of hypertension, diabetes, dementia, stroke, Parkinson’s disease, obesity, sleep apnea, and other chronic health conditions compared to inactive adults and similar risks compared to adults accruing their weekly exercise in a greater number of days. 2025 Feb;35(2):e70024. Scand J Med Sci Sports.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content